Clinical Trials Directory

Trials / Terminated

TerminatedNCT01452126

Minimum Effective Concentration of Ropivacaine for Brachial Plexus Block Via the Supraclavicular and Infraclavicular Approach, Femoral Nerve Block, Sciatic Nerve Block Via the Popliteal and Parasacral Approach

Minimum Effective Anesthetic Concentration of Supraclavicular Block, Infraclavicular Block, Femoral Nerve Block and Sciatic Nerve Block Via the Popliteal and Parasacral Approach

Status
Terminated
Phase
Phase 2
Study type
Interventional
Enrollment
49 (actual)
Sponsor
University of New Mexico · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a dose finding study to identify the minimum effective anesthetic concentration (MEAC) of ropivacaine to produce insensate body parts sufficient for surgery in supraclavicular and infraclavicular approaches to the brachial plexus, parasacral and popliteal approaches to the sciatic nerve, femoral nerve and transversus abdominis plane (TAP) blocks in adults.

Conditions

Interventions

TypeNameDescription
DRUGRopivacaine concentrationSingle shot preoperative perineural injection of ropivacaine to achieve surgical anesthesia. The concentration of ropivacaine is lowered by 0.05% after every successful surgical anesthesia specific to that block and raised by 0.05% after every unsuccessful surgical anesthesia specific to that block

Timeline

Start date
2011-06-01
Primary completion
2011-09-01
Completion
2011-09-01
First posted
2011-10-14
Last updated
2016-12-19
Results posted
2016-12-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01452126. Inclusion in this directory is not an endorsement.